Abstract:Ziwei Zhou, Xuan Liu, Xuejun Zhang, Shupeng Wen, Huan Hua, Zhenzhen Wang, Zheng Xu, Yu Lu, Fuxu Wang Department of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, Hebei 050000, People's Republic of China Correspondence: Fuxu Wang, Department of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, No. 215 West Heping Road, Shijiazhuang, Hebei, 050000, People's Republic of China, Tel +86 13931100360, Fax +86 031166003936, Email Background: Early immune reconstitution is crucial to successful outcomes after allogeneic stem cell transplantation (allo-HSCT). However, in T cell-replete HSCT, the impact of natural killer (NK) cells on transplantation outcome and the factors influencing early NK cell reconstitution remain unclear. Methods: In this retrospective study, we analyzed 128 patients with hematological malignancies who received the first T cell-replete allo-HSCT between May 2019 and September 2021. After application of a conditioning regimen, prophylaxis for graft versus host disease (GVHD), and engraftment, the patients received prevention and treatment procedures for cytomegalovirus (CMV) reactivation. NK cells, T lymphocytes and B lymphocytes in peripheral blood were collected and analyzed at 30, 60, 90, 135 and 180 days after transplantation to observe immune cell reconstitution. Overall survival (OS), relapse-free survival (RFS), minimal residual disease (MRD), relapse, and non-relapse mortality (NRM) were evaluated. SPSS 25.0 and R version 4.2.1 were used for statistical analysis. Results: In patients with rapid NK recovery (NK cell count at 30 days post-HSCT [NK30] > 165/μL and 60 days post-HSCT [NK60] > 265/μL), we observed lower rates of NRM, CMV reactivation and acute GVHD (aGVHD). Multivariate analysis indicated that a lower NK30 (≤ 165/μL) was an independent factor associated with inferior OS and RFS. The NK30 and NK60 in patients with CMV reactivation and aGVHD after transplantation were significantly lower than those in patients without these complications. In addition, CD107a expression in NK cells was also significantly lower in patients who experienced aGVHD. Correlation analysis did not find an inhibitory effect of T-lymphocyte subset reconstitution on NK cells in the early stage after transplantation. Conclusion: Rapid NK cell reconstitution early after allo-HSCT had protective effects on NRM and survival. Promoting early NK cell reconstitution represents a new approach to improving the outcomes of allo-HSCT. Keywords: allogeneic hematopoietic stem cell transplantation, immune reconstitution, natural killer cells, T-cell replete, non-relapse mortality In recent years, allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been the only major method to cure hematological malignancies. However, disease relapse after HSCT, graft versus host disease (GVHD), infection and other transplant-related complications continue to drive high mortality rates among patients. Ex vivo T-cell depletion (TCD) of the graft uses either positive selection or negative depletion of graft cells before infusion to effectively reduce the incidence of GVHD after transplantation. In contrast, T cell-repleted grafts consisting of non-manipulated bone marrow or peripheral blood grafts require intense in vivo GVHD prophylaxis. 1,2 Rapid reconstitution of the immune system after transplantation can give full play to the graft versus leukemia (GVL) effect and reduce the incidence of related complications. Studies have demonstrated a low transplantation-related mortality (TRM) rate among patients with a high lymphocyte recovery rate. 3 Natural killer (NK) cells are the first lymphocyte subset to recover after allo-HSCT. They can exert cytotoxicity against residual leukemia cells and infected cells without antigen stimulation. 4,5 The killing activity of NK cells after HSCT depends mainly on the mismatch between killer cell immunoglobulin-like receptors (KIRs) on the surface of donor NK cells and the major histocompatibility complex (MHC) I class molecules in recipients. 6,7 NK cells have been shown to be the main effector cells that eliminate leukemia cells in T cell-depleted allo-HSCT. Stable implantation of NK cells after HSCT can improve the prognosis of patients, as shown by an early study of 54 patients with acute myeloid leukemia (AML) who received T cell-depleted allo-HSCT that revealed lower incidence rates of acute GVHD (aGVHD), relapse, and TRM among patients with rapid early NK cell recovery. 8 In recent years, additional research has shown that rapid reconstitution of NK cells in the early stage after T cell-depleted and HLA-mismatched HSCT can signific -Abstract Truncated-

NK and T cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation

Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8(+) T Cells Within Donor Grafts: Its Associations with Cytomegalovirus Reactivation Following Unmanipulated Allogeneic Hematopoietic Stem Cell Transplantation.

Single-Cell Transcriptomics Reveals Adaptive NK Cell and Antigen-Specific T Cell Responses Shaped by CMV Viremia Post-Hematopoietic Stem Cell Transplant

Relationship Between T-cell Receptor Beta Chain Sequences and Human Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays

Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation

Poor NKG2C+Adaptive NK Cell Recovery at Early Stage after Allo-HSCT Increased the Occurrence of Refractory Cytomegalovirus Infection

Impaired T and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation

Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation

Cytomegalovirus-specific T cell immunity reconstitution following allogeneic hematopoietic stem cell transplantation: a pilot stduy

Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation

Rapid Reconstitution of NK1 Cells after Allogeneic Transplantation is Associated with a Reduced Incidence of Graft-Versus-host Disease

Early CMV Replication-Associated Anti-Leukemia Effect Is Related to the Reconstitution of Specific Subsets of Natural Killer Cells after Haploidentical Stem Cell Transplantation in Acute Leukemia

Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation

Evolution of Cytomegalovirus-Responsive T Cell Clonality following Solid Organ Transplantation

Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation

Recovery of Specific Subsets of Natural Killer and T Cells Highly Associated with Graft-Versus-Host Disease after Haploidentical Stem Cell Transplantation in Acute Leukemia

Reconstitution of Natural Killer Cell Receptor Repertoires after Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Transplantation: Analyses of CD94:NKG2A and Killer Immunoglobulin-Like Receptor Expression and Their Associations with Clinical Outcome

Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution

Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice

Expansion of effector memory Vδ2neg γδ T cells associates with cytomegalovirus reactivation in allogeneic stem cell transplant recipients